Head-to-head · Cost-Efficiency Index
Welling Health vs Renlo Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Welling Health
Patients willing to log meals daily in exchange for a lower effective GLP-1 price.
Visit Welling HealthRenlo Health
Someone who wants a flat monthly bill that will not step up, with a refund route if it does not work.
Visit Renlo HealthThe verdict
Welling Health and Renlo Health tie on the Cost-Efficiency Index at 78/100, so neither wins outright on the numbers. For most shoppers we'd start with Welling Health (ranked #40, a hair above #42) — Patients willing to log meals daily in exchange for a lower effective GLP-1 price. But Renlo Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Welling Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Welling Health | Renlo Health |
|---|---|---|
| Cost-Efficiency Index | 78/100 | 78/100 |
| Semaglutide / mo | $190/mo (all doses, promotional rate, compounded) | $199/mo, billed monthly at every dose |
| Tirzepatide / mo | $275/mo (all doses, compounded) | $269/mo, billed monthly at every dose |
| Semaglutide / yr (modeled) | $2,280 | $2,388 |
| Tirzepatide / yr (modeled) | $3,300 | $3,228 |
| Coverage | All 50 states | Not disclosed |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #40 | #42 |
Welling Health
78/100Where the value is
- Flat, dose-independent base pricing with no setup or consultation fees disclosed
- Licensed in all 50 states
- Named pharmacy tier (LegitScript-certified 503A, USP <797>) even though the specific pharmacy isn't named
The tradeoffs
- The eye-catching ~30%-off streak price is not the standing rate — it requires 30 unbroken consecutive days of in-app meal logging and resets if a day is missed, so $190/$275 is the realistic price for most patients most of the time
- Tirzepatide's $275 base rate is on the higher end of compounded competitors in this batch
Renlo Health
78/100Where the value is
- The headline is the real month-to-month rate — no prepay division and no commitment behind an asterisk
- Names the prescribing physician, Dr. Sean Arora, MD, and the dispensing pharmacy, VialsRX
- Same price at every dose with a price-lock badge, so titrating up never moves the bill
The tradeoffs
- A struck-through $299 sits beside the price with no published basis — Renlo never says what it was, when it applied or to whom
- That strikethrough comes from a stylesheet rule rather than a struck-out element, so a markup-level check would report the page clean
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.